Real-time enrollment status for this mcrpc (metastatic castration-resistant prostate cancer) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 1:14 PM UTC
| NCT Number | NCT06190899 |
| Recruiting Status | Recruiting |
| Condition | mCRPC (Metastatic Castration-resistant Prostate Cancer) |
| Phase | Clinical Trial |
| Target Enrollment | 54 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Celcuity Inc |
| Last Updated on CT.gov | April 13, 2026 (Apr 13, 2026) |
As of July 13, 2026: Clinical trial NCT06190899 is currently recruiting participants. This clinical trial study for mcrpc (metastatic castration-resistant prostate cancer) is actively seeking new participants at 1 location across the United States. The study is sponsored by Celcuity Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06190899 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06190899 was last updated Apr 13, 2026 (April 13, 2026). HelloStudys verifies this status automatically.